Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Comparative IgG responses to SARS-CoV-2 after natural infection or vaccination

View ORCID ProfileKaylan M. Olds, View ORCID ProfileDevon P. Humphreys, View ORCID ProfileKathleen M. Gavin, View ORCID ProfileAnne L. Wyllie, View ORCID ProfileTimothy A. Bauer
doi: https://doi.org/10.1101/2022.09.28.22280476
Kaylan M. Olds
1Everly Health, Inc., 823 Congress Ave, STE 1200, Austin TX 78701
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kaylan M. Olds
Devon P. Humphreys
1Everly Health, Inc., 823 Congress Ave, STE 1200, Austin TX 78701
MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Devon P. Humphreys
Kathleen M. Gavin
1Everly Health, Inc., 823 Congress Ave, STE 1200, Austin TX 78701
2University of Colorado Anschutz Medical Campus, Aurora, CO 80045
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kathleen M. Gavin
Anne L. Wyllie
3Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anne L. Wyllie
Timothy A. Bauer
1Everly Health, Inc., 823 Congress Ave, STE 1200, Austin TX 78701
2University of Colorado Anschutz Medical Campus, Aurora, CO 80045
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Timothy A. Bauer
  • For correspondence: tbauer{at}everlyhealth.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Article Information

doi 
https://doi.org/10.1101/2022.09.28.22280476
History 
  • October 2, 2022.

Article Versions

  • Version 1 (September 29, 2022 - 10:48).
  • You are viewing Version 2, the most recent version of this article.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Kaylan M. Olds, MS1,
  2. Devon P. Humphreys, MA1,
  3. Kathleen M. Gavin, PhD1,2,
  4. Anne L. Wyllie, PhD3 and
  5. Timothy A. Bauer, PhD1,2,*
  1. 1Everly Health, Inc., 823 Congress Ave, STE 1200, Austin TX 78701
  2. 2University of Colorado Anschutz Medical Campus, Aurora, CO 80045
  3. 3Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510
  1. ↵*Corresponding Author Address for correspondence:
    Timothy Bauer, PhD, Everly Health, Inc., 823 Congress Ave., Suite 1200, Austin, TX 78701; phone: 303-503-5713; email: tbauer{at}everlyhealth.com
Back to top
PreviousNext
Posted October 02, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Comparative IgG responses to SARS-CoV-2 after natural infection or vaccination
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Comparative IgG responses to SARS-CoV-2 after natural infection or vaccination
Kaylan M. Olds, Devon P. Humphreys, Kathleen M. Gavin, Anne L. Wyllie, Timothy A. Bauer
medRxiv 2022.09.28.22280476; doi: https://doi.org/10.1101/2022.09.28.22280476
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Comparative IgG responses to SARS-CoV-2 after natural infection or vaccination
Kaylan M. Olds, Devon P. Humphreys, Kathleen M. Gavin, Anne L. Wyllie, Timothy A. Bauer
medRxiv 2022.09.28.22280476; doi: https://doi.org/10.1101/2022.09.28.22280476

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)